Kurse um 15 Minuten verzögert
Die Reihe ist auf die aktuelle Aktienzahl nach Splits umgerechnet; Dividenden sind nicht im Kurs enthalten
| Datum | Eröffnung | Hoch | Tief | Schluss | Volumen, Stück |
|---|---|---|---|---|---|
| 16. September 2026 | 146,58 | 149,30 | 146,12 | 147,68 | 5 Mio. |
| 15. September 2026 | 144,00 | 146,35 | 142,94 | 146,30 | 5 Mio. |
| 14. September 2026 | 144,26 | 146,75 | 143,71 | 146,41 | 5 Mio. |
| 11. September 2026 | 145,24 | 145,99 |
Auf Basis der Berichte bis 31. Dezember 2025
Gilead is built on antivirals: HIV supplies the revenue, oncology the hope for the future.
The core is HIV treatment and prevention. That is a durable market: therapy is lifelong, adherence is high, and prevention widens the population beyond those already infected. The company steadily extends the franchise's commercial life with longer-acting formulations.
The hepatitis C story is an important lesson in the company's biography: those medicines cured the disease outright, and revenue collapsed once the queue of patients was treated. A rare case where a drug's effectiveness destroyed its own market.
The replacement direction is oncology, including cell therapy after the Kite acquisition. It has not yet replaced the core income, and its progress is the main focus for investors. Gilead pays a substantial dividend.
Adresse:333 LAKESIDE DR, FOSTER CITY, CA, 94404, US
| 226 Mio. |
| HALOHalozyme Therapeutics, Inc. | 111,78 | +1,91 % | 211 Mio. |
| TECHBio-Techne Corp | 72,38 | −0,05 % | 192 Mio. |
| NBIXNeurocrine Biosciences, Inc. | 149,67 | −1,43 % | 173 Mio. |
| RGENRepligen Corporation | 178,30 | +6,20 % | 165 Mio. |
| 143,50 |
| 143,72 |
| 4 Mio. |
| 10. September 2026 | 145,07 | 145,91 | 143,67 | 144,81 | 6 Mio. |
| 09. September 2026 | 145,46 | 147,68 | 145,00 | 145,65 | 5 Mio. |
| 08. September 2026 | 146,98 | 148,65 | 145,45 | 146,64 | 6 Mio. |
| 04. September 2026 | 149,23 | 151,19 | 149,23 | 151,00 | 6 Mio. |
| 03. September 2026 | 150,67 | 151,48 | 148,41 | 151,22 | 4 Mio. |
| 02. September 2026 | 150,00 | 152,55 | 148,83 | 149,61 | 5 Mio. |
| 01. September 2026 | 148,52 | 149,96 | 146,92 | 149,92 | 5 Mio. |
| 31. August 2026 | 144,23 | 147,22 | 143,18 | 146,34 | 7 Mio. |
| 28. August 2026 | 149,47 | 149,47 | 144,88 | 145,68 | 4 Mio. |
| 27. August 2026 | 147,30 | 149,11 | 146,01 | 148,86 | 5 Mio. |
| 26. August 2026 | 148,00 | 149,62 | 147,00 | 148,09 | 5 Mio. |
| 25. August 2026 | 146,60 | 148,94 | 145,58 | 148,77 | 5 Mio. |
| 24. August 2026 | 145,93 | 146,84 | 144,59 | 146,74 | 6 Mio. |
| 21. August 2026 | 144,52 | 147,91 | 143,50 | 146,12 | 5 Mio. |
| 20. August 2026 | 146,69 | 146,82 | 143,19 | 143,44 | 7 Mio. |
| 19. August 2026 | 145,10 | 148,97 | 144,30 | 147,60 | 7 Mio. |